(TDOC) Teladoc - Ratings and Ratios

Teladoc Health, Inc. (NYSE:TDOC) is a global leader in virtual healthcare, delivering comprehensive medical and mental health services through its dual operating segments: Teladoc Health Integrated Care and BetterHelp. The Integrated Care segment provides a wide range of virtual medical services, including general medical consultations, specialist referrals, chronic condition management, and mental health support. It also offers enterprise-level telehealth solutions for hospitals and health systems, enabling seamless integration of virtual care into traditional healthcare infrastructure. The BetterHelp segment operates a leading mental health platform, connecting individuals with licensed clinicians for counseling and therapy through multiple interaction channels, including video, phone, and text-based communication. The company serves a diverse client base, including employers, health plans, hospitals, insurance providers, and individual consumers, under its Teladoc, Livongo, and BetterHelp brands. Teladoc Health, Inc. was founded in 2002 and is headquartered in Purchase, New York.

From a technical perspective, TDOC is currently trading at $7.06, below its SMA 20 ($7.14), SMA 50 ($8.26), and SMA 200 ($9.09), indicating bearish momentum. The stocks Average True Range (ATR) of 0.47 reflects moderate volatility. On the fundamental side, the company has a market capitalization of $1.225 billion, with a forward P/E of 357.14, signaling high expectations for future earnings despite current losses. The price-to-book (P/B) ratio of 0.86 and price-to-sales (P/S) ratio of 0.48 suggest undervaluation relative to its assets and revenue. However, the return on equity (RoE) of -70.94% highlights significant profitability challenges.